申联生物：持股5%以上股东权益变动，持股比例降至10%

Core Viewpoint - The company received a notification from United BioPharma regarding a planned share reduction through centralized bidding from November 24 to 28, 2025, which will decrease the shareholder's stake from 10.52% to 10.00% [1] Summary by Relevant Sections - Shareholder Action - The shareholder will reduce their holdings by selling shares, resulting in a total of 41,064,498 shares held post-reduction [1] - Impact on Company - The reduction does not violate any commitments, does not trigger mandatory tender offer obligations, and will not lead to changes in the company's controlling shareholder or actual controller [1] - The operational impact on the company is deemed minimal [1]